Pacific Edge Limited (PEB.AX)
AUD 0.11
(-4.35%)
AUD 0.11
(-4.35%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -37.1 Million NZD | -13.13% |
| 2023 | -32.79 Million NZD | -50.44% |
| 2022 | -21.8 Million NZD | 1.34% |
| 2021 | -15.44 Million NZD | -14.62% |
| 2020 | -19.27 Million NZD | -1.34% |
| 2019 | -19.02 Million NZD | 10.45% |
| 2018 | -20.94 Million NZD | 3.04% |
| 2017 | -21.91 Million NZD | -26.01% |
| 2016 | -17.38 Million NZD | -39.08% |
| 2015 | -12.5 Million NZD | -26.51% |
| 2014 | -9.56 Million NZD | -47.08% |
| 2013 | -6.71 Million NZD | -54.46% |
| 2012 | -4.35 Million NZD | -33.89% |
| 2011 | -2.81 Million NZD | 3.25% |
| 2010 | -3.35 Million NZD | -17.29% |
| 2009 | -2.86 Million NZD | -58.53% |
| 2008 | -1.8 Million NZD | -4.65% |
| 2007 | -1.72 Million NZD | -1.76% |
| 2006 | -1.69 Million NZD | 21.12% |
| 2005 | -2.15 Million NZD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q4 | -7.74 Million NZD | 0.0% |
| 2024 Q1 | -8.66 Million NZD | -1.38% |
| 2024 Q2 | -8.66 Million NZD | 0.0% |
| 2024 Q3 | -7.74 Million NZD | 10.57% |
| 2024 FY | - NZD | -13.13% |
| 2023 Q4 | -8.54 Million NZD | 0.0% |
| 2023 FY | - NZD | -50.44% |
| 2023 Q3 | -8.54 Million NZD | -18.98% |
| 2023 Q2 | -7.18 Million NZD | 0.0% |
| 2023 Q1 | -7.18 Million NZD | -33.14% |
| 2022 Q2 | -4.7 Million NZD | 0.0% |
| 2022 Q3 | -5.39 Million NZD | -14.69% |
| 2022 Q4 | -5.39 Million NZD | 0.0% |
| 2022 FY | - NZD | 1.34% |
| 2022 Q1 | -4.7 Million NZD | -17.3% |
| 2021 Q2 | -3.71 Million NZD | 0.0% |
| 2021 Q1 | -3.71 Million NZD | 22.19% |
| 2021 Q4 | -4.01 Million NZD | 0.0% |
| 2021 FY | - NZD | -14.62% |
| 2021 Q3 | -4.01 Million NZD | -8.07% |
| 2020 Q3 | -4.76 Million NZD | -1.63% |
| 2020 FY | - NZD | -1.34% |
| 2020 Q4 | -4.76 Million NZD | 0.0% |
| 2020 Q2 | -4.69 Million NZD | 0.0% |
| 2020 Q1 | -4.69 Million NZD | -1.32% |
| 2019 Q3 | -4.63 Million NZD | -6.63% |
| 2019 FY | - NZD | 10.45% |
| 2019 Q1 | -4.34 Million NZD | 11.23% |
| 2019 Q4 | -4.63 Million NZD | 0.0% |
| 2019 Q2 | -4.34 Million NZD | 0.0% |
| 2018 Q1 | -4.92 Million NZD | 11.99% |
| 2018 FY | - NZD | 3.04% |
| 2018 Q4 | -4.89 Million NZD | 0.0% |
| 2018 Q2 | -4.92 Million NZD | 0.0% |
| 2018 Q3 | -4.89 Million NZD | 0.73% |
| 2017 Q3 | -5.6 Million NZD | -32.84% |
| 2017 Q4 | -5.6 Million NZD | 0.0% |
| 2017 FY | - NZD | -26.01% |
| 2017 Q2 | -4.21 Million NZD | 0.0% |
| 2017 Q1 | -4.21 Million NZD | 6.49% |
| 2016 FY | - NZD | -39.08% |
| 2016 Q4 | -4.5 Million NZD | 0.0% |
| 2016 Q1 | -3.54 Million NZD | 10.61% |
| 2016 Q2 | -3.54 Million NZD | 0.0% |
| 2016 Q3 | -4.5 Million NZD | -27.21% |
| 2015 Q4 | -3.96 Million NZD | 0.0% |
| 2015 FY | - NZD | -26.51% |
| 2015 Q3 | -3.96 Million NZD | -59.37% |
| 2015 Q2 | -2.48 Million NZD | 0.0% |
| 2015 Q1 | -2.48 Million NZD | -11.59% |
| 2014 Q2 | -2.43 Million NZD | 0.0% |
| 2014 Q1 | -2.43 Million NZD | -98.24% |
| 2014 FY | - NZD | -47.08% |
| 2014 Q4 | -2.22 Million NZD | 0.0% |
| 2014 Q3 | -2.22 Million NZD | 8.51% |
| 2013 Q3 | -1.22 Million NZD | 0.0% |
| 2013 Q4 | -1.22 Million NZD | 0.0% |
| 2013 FY | - NZD | -54.46% |
| 2012 FY | - NZD | -33.89% |
| 2011 FY | - NZD | 3.25% |
| 2010 FY | - NZD | -17.29% |
| 2009 FY | - NZD | -58.53% |
| 2008 FY | - NZD | -4.65% |
| 2007 FY | - NZD | -1.76% |
| 2006 FY | - NZD | 21.12% |
| 2005 FY | - NZD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Australian Clinical Labs Limited | 181.83 Million AUD | 120.406% |
| BCAL Diagnostics Limited | -5.66 Million AUD | -554.769% |
| Genetic Signatures Limited | -20.33 Million AUD | -82.44% |
| Genetic Technologies Limited | -11.43 Million AUD | -224.604% |
| Healius Limited | -298.09 Million AUD | 87.553% |
| Imagion Biosystems Limited | -13.69 Million AUD | -170.9% |
| Integral Diagnostics Limited | 12.33 Million AUD | 400.831% |
| INOVIQ Ltd | -6.63 Million AUD | -459.361% |
| Microba Life Sciences Limited | -22.8 Million AUD | -62.675% |
| Monash IVF Group Limited | 13.02 Million AUD | 384.872% |
| Rhythm Biosciences Limited | -6.79 Million AUD | -445.985% |
| Sonic Healthcare Limited | 1.65 Billion AUD | 102.236% |